Tag: Immunotherapy
Zydus launches Tishtha, the world’s first biosimilar of Nivolumab, in India...
The immunotherapy reduces treatment burden by making it accessible at approximately 1/4th cost of the reference drug
Zydus, Formycon forge exclusive deal to license & supply Keytruda biosimilar...
The BLA application is expected to be submitted to the USFDA in the near future and is aimed at making immunotherapy affordable and accessible to patients in need
Signature genes that predict T-Cell expansion in cancer immunotherapy
By tracking immune cells in tumors over time, researchers identify genes that predict CD8+ T cell expansion in the tumor
RGCON 2025: Gynecological cancers in India expected to rise by 55%...
The conference focused on the latest innovations in gynecological cancer care, including new technologies, advance surgical techniques, and immunotherapy
IL-35-Mediated Immunotherapy: A new treatment for Type I & autoimmune diabetes...
The growing global diabetes epidemic that disproportionately affects developing country children and adolescents calls for effective treatment for the disease
Amrita Hospital unveils North India’s first Centre of Excellence for CAR...
Pioneering cancer treatment for blood cancers in collaboration with leading immunotherapy experts to revolutionize care in the NCR
RGCIRC hosts Breast Cancer Update Conference 2024
The conference showcases groundbreaking advances in cancer research, recognizes key findings from global forums
CAR-T cell therapy gives a new lease of life to a...
Following a thorough evaluation, the patient achieved molecular remission post-immunotherapy and was later planned for CAR T-cell therapy
Narayana Health City’s CAR T-cell therapy triumphs in cancer treatment
Bangalore Hospital celebrates first successful CAR T-cell therapy for relapsed lymphoma in South India
Cytek Biosciences partners with Bio-Rad to expand reagent portfolios
New agreement enhances high-parameter panels on Cytek Cell Analysis Systems